
Omecu
The next standard in genomics analysis.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Grant | |
Total Funding | 000k |
USD | 2023 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Omecu operates in the genomic data analysis sector, providing a cloud-based platform optimized for real-time, interactive analysis of large genomic and health-related datasets. The platform is designed to enhance user experience by allowing clients to derive actionable insights swiftly, without the delays typically associated with data processing. Omecu's architecture ensures data security, enabling users to maintain control over their data within their own environments. The company primarily serves clients in the healthcare and research industries, focusing on customer satisfaction and efficient data handling. Omecu's business model likely involves subscription-based access to its platform, generating revenue through service fees. The company positions itself as a key player in the fast-evolving field of genomic analysis, addressing the growing demand for rapid and secure data processing solutions.
Keywords: genomic, data analysis, cloud-based, real-time, secure, insights, healthcare, research, platform, customer satisfaction